Details of the Drug
General Information of Drug (ID: DM0NTA3)
| Drug Name |
(4-phenylpiperazin-1-yl)(p-tolyl)methanone
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
(4-Phenyl-piperazin-1-yl)-p-tolyl-methanone; piperazine, a2; Cambridge id 5345452; AC1LF9G0; Oprea1_767331; Oprea1_285639; CHEMBL239457; SCHEMBL10721885; BDBM25773; MolPort-001-016-695; ZINC196133; HMS1676A12; STK020131; AKOS000671240; MCULE-2746904510; BAS 00500757; 4-methylphenyl 4-phenylpiperazinyl ketone; ST50682677; AB00081719-01; 1-[(4-methylphenyl)carbonyl]-4-phenylpiperazine; SR-01000406866; (4-methylphenyl)(4-phenylpiperazin-1-yl)methanone; (4-methylphenyl)-(4-phenylpiperazin-1-yl)methanone
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 280.4 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


